Glaucoma.
D000136:Acid-Base Equilibrium; D000818:Animals; D003263:Contact Lenses, Hydrophilic; D003692:Delayed-Action Preparations; D005901:Glaucoma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006892:Hydroxydopamines / Q000627:therapeutic use*; D007429:Intraocular Pressure / Q000187:drug effects*; D009900:Optic Nerve / Q000378:metabolism; D009902:Optic Neuritis / Q000517:prevention & control; D010672:Phenytoin / Q000627:therapeutic use*; D010862:Pilocarpine / Q000008:administration & dosage / Q000627:therapeutic use*; D011817:Rabbits; D012964:Sodium / Q000378:metabolism
D003692:Delayed-Action Preparations; D006892:Hydroxydopamines; D010862:Pilocarpine; D010672:Phenytoin; D012964:Sodium